Avinza Elan

Autor: Marilyn R, Semenchuk
Rok vydání: 2002
Předmět:
Zdroj: Current opinion in investigational drugs (London, England : 2000). 3(9)
ISSN: 1472-4472
Popis: Avinza is a once-daily morphine sulfate controlled-release formulation utilizing SODAS (Spheroidal Oral Drug Absorption System) technology developed by Elan and Ligand for the potential treatment of pain [220806], [223862]. This multiparticulate product is designed to provide a rapid onset of action together with a sustained therapeutic effect over 24 h. It is thought that once-daily administration should improve compliance and help eliminate breakthrough pain which is a feature of many twice-daily products, thereby providing better pain management [220806].
Databáze: OpenAIRE